Pre-Open Stock Movers:

Tufin (NYSE: TUFN) 44% HIGHER; Entered into a definitive agreement to be acquired by Turn/River Capital, a software-focused investment firm, in an all-cash transaction that values Tufin at approximately $570 million.

BioXcel Therapeutics, Inc. (Nasdaq: BTAI) 19% HIGHER; The FDA approved IGALMI sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults

Array Technologies Inc. (NASDAQ: ARRY) 13% HIGHER; reported Q4 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $219.9 million versus the consensus estimate of $213.82 million. The company sees FY2022 EPS of $0.55-$0.74, versus the consensus of $0.66, and FY2022 revenue of $1.45-1.75 billion, versus the consensus of $1.39 billion.

Tilray, Inc. (NASDAQ: TLRY) 13% HIGHER; reported Q3 EPS of $0.09, versus ($1.03) reported last year. Revenue for the quarter came in at $151.9 million, versus $123.9 million reported last year.

Gogo Inc. (NASDAQ: GOGO) 10% HIGHER; picked to replace SPX FLOW in the S&P SmallCap 600.

Cano Health (NYSE: CANO) 9% LOWER; Piper Sandler downgraded to Underweight as reported results overstated visibility, growth, and profitability.

Avis Budget Group (NASDAQ: CAR) 6% LOWER; BofA Securities downgraded to Underperform.

JetBlue Airways (NASDAQ: JBLU) 4% LOWER; confirmed it made a $33/share bid for Spirit Airlines, Inc. (NYSE: SAVE).

Spirit Airlines, Inc. (NYSE: SAVE) 4% LOWER; Shares consolidate today's 22.4% gains following confirmation that JetBlue Airways made a $33/share bid.

Atreca, Inc. (NASDAQ: BCEL) 3% HIGHER; entered a licensing agreement with Zymework to utilize their ZymeLink technology to develop novel antibody-drug conjugates (ADCs) and declared ATRC-301, an ADC targeting a novel epitope on EphA2, as the Companys next clinical candidate.

Rivian Automotive, Inc. (NASDAQ: RIVN) 2% HIGHER; produced 2,553 vehicles and delivered 1,227 during the first quarter, which are in line with the EV company’s expectations.